MATTHEW STAUB: Open Payments
NPI 1508134784 · GETTYSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $186 |
| SCPHARMACEUTICALS INC. | 4 | $95 |
| TREACE MEDICAL CONCEPTS, INC. | 1 | $56 |
| Boston Scientific Corporation | 1 | $36 |
| Novo Nordisk Inc | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: ELIQUIS, FUROSCIX, CAMZYOS, TMC NANOPLASTY SYSTEM, Varithena Administration Pack, Wegovy, LEQVIO, Kerendia.
Industry payments across PA — which companies pay providers there.
